Analyst Price Targets — ACH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2026 12:07 pm | — | UBS | $1.50 | $1.12 | TheFly | Accendra Health price target lowered to $1.50 from $4.50 at UBS |
| August 11, 2026 6:49 am | Eric Coldwell | Robert W. Baird | $1.50 | $1.40 | StreetInsider | Baird Downgrades Accendra Health Inc. (ACH) to Neutral |
| May 12, 2026 12:51 pm | — | UBS | $4.50 | $3.34 | TheFly | Accendra Health price target raised to $4.50 from $3 at UBS |
| May 12, 2026 10:26 am | — | Robert W. Baird | $6.00 | $3.89 | TheFly | Accendra Health price target raised to $6 from $5 at Baird |
| February 22, 2026 7:17 pm | Kevin Caliendo | UBS | $3.00 | $2.61 | TheFly | Accendra Health price target lowered to $3 from $4 at UBS |
| January 6, 2026 2:32 pm | Eric Coldwell | Robert W. Baird | $5.00 | $9.04 | TheFly | Accendra Health price target lowered to $5 from $7 at Baird |
| November 3, 2025 9:06 am | Kevin Caliendo | UBS | $4.00 | $3.97 | StreetInsider | UBS Downgrades Owens & Minor (OMI) to Neutral |
| August 13, 2025 9:40 am | Kevin Caliendo | UBS | $7.00 | $5.47 | TheFly | Owens & Minor price target lowered to $7 from $13 at UBS |
| August 11, 2025 7:11 am | Michael Minchak | J.P. Morgan | $10.00 | $7.09 | Benzinga | Top Wall Street Forecasters Revamp Owens & Minor Expectations Ahead Of Q2 Earnings |
| August 8, 2025 8:56 am | Eric Coldwell | Robert W. Baird | $10.00 | $7.09 | TheFly | Owens & Minor upgraded to Outperform from Neutral at Baird |
Latest News for ACH
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE's continued listing standards because the average closing price of the Company's Class A Common Stock (the “Common Stock”) was less than $1.00 per…
ACH, ARDX and DPRO have been added to the Zacks Rank #5 (Strong Sell) List on October 9th, 2026.
VLVLY, ACH and CCJ have been added to the Zacks Rank #5 (Strong Sell) List on October 6th, 2026.
Accendra Health, Inc. (NYSE: ACH) (the âCompanyâ) today named Kenneth Gardner-Smith as the Company's next President and Chief Executive Officer. Gardner-Smi
RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) today named Kenneth Gardner-Smith as the Company's next President and Chief Executive Officer. Gardner-Smith, who has served on the Company's Board of Directors since March 2022, is expected to assume the role early in the fourth quarter 2026. He will succeed Edward A. Pesicka, who announced his intent to retire in August.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACH.
U.S. House Trading
No House trades found for ACH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.